Company Overview and News

4
China lures chip talent from Taiwan with fat salaries, perks

2018-09-04 theedgemarkets
TAIPEI (Sep 4): A huge pay rise, eight free trips home a year and a heavily subsidized apartment. It was a dream job offer that a Taiwanese engineer simply could not refuse.
SIUIF AAPL UMC 0981 SMI

4
China lures chip talent from Taiwan with fat salaries, perks

2018-09-04 malaymail
TAIPEI, Sept 4 — A huge pay rise, eight free trips home a year and a heavily subsidised apartment. It was a dream job offer that a Taiwanese engineer simply could not refuse.
SIUIF AAPL UMC 0981 SMI

4
China lures chip talent from Taiwan with fat salaries, perks

2018-09-04 channelnewsasia
A huge pay rise, eight free trips home a year and a heavily subsidised apartment. It was a dream job offer that a Taiwanese engineer simply could not refuse.
SIUIF AAPL UMC 0981 SMI

4
China lures chip talent from Taiwan with fat salaries, perks

2018-09-04 reuters
TAIPEI (Reuters) - A huge pay rise, eight free trips home a year and a heavily subsidized apartment. It was a dream job offer that a Taiwanese engineer simply could not refuse.
SIUIF AAPL UMC 0981 SMI

 
Semiconductor Manufacturing International Corporation 2018 Q2 - Results - Earnings Call Slides

2018-08-10 seekingalpha
The following slide deck was published by Semiconductor Manufacturing International Corporation in conjunction with their 2018 Q2 earnings call.
SIUIF 0981 SMI

244
Taiwan’s Technology Secrets Come Under Assault From China - WSJ

2018-07-01 wsj
HSINCHU, Taiwan—In late 2016, an engineer at Taiwan Semiconductor Manufacturing Co., the world’s largest contract chip manufacturer, received a call from a Chinese rival company asking if he would be interested in a job as chief engineer to advance work on chips used in mobile phones and game consoles.
SIUIF AAPL UMC NVDA 0981 QCOM SMI SPIL

13
US-China trade tussle forces China to reform faster, says asset manager Amundi

2018-06-21 scmp
Beijing is shifting its policy focus from cutting overcapacity to upgrading the value chain with national grants and support to IP that protect Chinese corporate interests
SIUIF 0981 SMI

32
Semiconductor Manufacturing International's (SMI) CEO Haijun Zhao on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Semiconductor Manufacturing International Corporation (NYSE:SMI) Q1 2018 Earnings Conference Call May 10, 2018 8:30 PM ET
TXN SIUIF MS 0981 SMI

13
Semiconductor Manufacturing International Corporation 2018 Q1 - Results - Earnings Call Slides

2018-05-12 seekingalpha
The following slide deck was published by Semiconductor Manufacturing International Corporation in conjunction with their 2018 Q1 earnings call.
SIUIF 0981 SMI

25
SMI / Semiconductor Manufacturing International Corp. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-05-07 fintel.io
Semiconductor Manufacturing International Corp. (NYSE:SMI) has 75 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 804,465,586 shares. Largest shareholders include Datang Telecom Technology & Industry Holdings Co., Ltd., Dimensional Fund Advisors Lp, Renaissance Technologies LLC, Central Asset Investments & Management Holdings (HK) Ltd, Parametric Portfolio Associates Llc, Bank Of Montreal /can/, Millennium Management Llc, UBS Group AG, Profund Advisors Llc, and Aperio Group, LLC.
BMO BMQZF SIUIF UBS BMO 0981 SMI ULSGF

13
China Invites Foreign Cash to Build a World-Class Chip Industry - Bloomberg

2018-04-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SIUIF 0981 SMI

370
Chipmakers' Rout Widens After TSMC Ignites Smartphone Fears - Bloomberg

2018-04-20 bloomberg - 1
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SIUIF HXSCF STM BC94 SMSN DLGNF NVDA 0981 TOELY AMAT AAPL AVGO STM STMEF BRCM QCOM TOELF 8035 SMI 8036 SMSD HXSCL

43
China looks to speed up chip plans as U.S. trade tensions boil

2018-04-20 scmp - 1
China’s chip push is at the heart of the trade stand-off with the United States. Beijing wants to boost its tech prowess and escape from its reliance on U.S. products. Washington sees the move as a direct challenge.
SIUIF INTC 0981 QCOM SMI

42
Exclusive: China looks to speed up chip plans as US trade tensions boil - sources

2018-04-19 channelnewsasia
China is looking to accelerate plans to develop its domestic semiconductor market amid a fierce trade stand-off with the United States and a U.S. ban on sales to Chinese phone maker ZTE that has underscored the country's reliance on imported chips.
SIUIF INTC 0981 QCOM SMI

42
Exclusive: China looks to speed up chip plans as U.S. trade tensions boil - sources

2018-04-19 reuters
BEIJING (Reuters) - China is looking to accelerate plans to develop its domestic semiconductor market amid a fierce trade stand-off with the United States and a U.S. ban on sales to Chinese phone maker ZTE that has underscored the country’s reliance on imported chips.
SIUIF INTC 0981 QCOM SMI

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...